Ad is loading...
GATMX
Price
$12.61
Change
-$0.10 (-0.79%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

GATMX vs VTSNX

Header iconGATMX vs VTSNX Comparison
Open Charts GATMX vs VTSNXBanner chart's image
Goldman Sachs International T/M Eq A
Price$12.61
Change-$0.10 (-0.79%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
GATMX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GATMX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GATMX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. GATMX (918M). VTSNX pays higher dividends than GATMX: VTSNX (3.29) vs GATMX (1.81). GATMX was incepted earlier than VTSNX: GATMX (17 years) vs VTSNX (14 years). GATMX is a more actively managed with annual turnover of: 132.00 vs. VTSNX (4.00). GATMX has a lower initial minimum investment than VTSNX: GATMX (1000) vs VTSNX (5000000). GATMX annual gain was more profitable for investors over the last year : 14.24 vs. VTSNX (10.92). GATMX return over 5 years is better than : 36.41 vs. VTSNX (15.91).
GATMXVTSNXGATMX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD6.5034.535143%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets918M442B0%
Annual Yield % from dividends1.813.2955%
Returns for 1 year14.2410.92130%
Returns for 3 years8.22-5.86-140%
Returns for 5 years36.4115.91229%
Returns for 10 years69.8529.81234%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals